Alessandro Sarcinella
Overview
Explore the profile of Alessandro Sarcinella including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
28
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sarcinella A, Femmino S, Brizzi M
Int J Mol Sci
. 2023 Nov;
24(21).
PMID: 37958693
Non-healing wound- and tissue-injury are commonly experienced worldwide by the aging population. The persistence of disease commonly leads to tissue infection, resulting in severe clinical complications. In the last decade,...
2.
Koni M, Lopatina T, Grange C, Sarcinella A, Cedrino M, Bruno S, et al.
Pharmacol Res
. 2023 Jul;
195:106871.
PMID: 37506784
Circulating tumour-derived extracellular vesicles are supposed to contribute to the spreading of distant metastasis. In this study, we investigated the impact of circulating extracellular vesicles derived from tumour-endothelial cells (TEVs)...
3.
Salemme V, Vedelago M, Sarcinella A, Moietta F, Piccolantonio A, Moiso E, et al.
Nat Commun
. 2023 May;
14(1):2350.
PMID: 37169737
The p140Cap adaptor protein is a tumor suppressor in breast cancer associated with a favorable prognosis. Here we highlight a function of p140Cap in orchestrating local and systemic tumor-extrinsic events...
4.
Gibello L, DAntico S, Salafia M, Senetta R, Pomatto M, Orlando G, et al.
Pharmacol Res
. 2023 Mar;
190:106718.
PMID: 36878306
Current therapeutic approaches for chronic venous ulcers (CVUs) still require evidence of effectiveness. Diverse sources of extracellular vesicles (EVs) have been proposed for tissue regeneration, however the lack of potency...
5.
Lopatina T, Sarcinella A, Brizzi M
Cancers (Basel)
. 2022 Aug;
14(16).
PMID: 36011012
Control of the immune response is crucial for tumour onset and progression. Tumour cells handle the immune reaction by means of secreted factors and extracellular vesicles (EV). Tumour-derived extracellular vesicles...
6.
Koni M, Castellano I, Venturelli E, Sarcinella A, Lopatina T, Grange C, et al.
Cancers (Basel)
. 2022 Aug;
14(16).
PMID: 36010912
Tumour molecular annotation is mandatory for biomarker discovery and personalised approaches, particularly in triple-negative breast cancer (TNBC) lacking effective treatment options. In this study, the interleukin-3 receptor α (IL-3Rα) was...